# Biotech Daily Digest ‚Äî 2026-01-09

**47 items from 4 sources**

## Summary by Source

- Eli Lilly Press Releases: 1 item
- Endpoints News: 13 items
- Fierce Biotech: 10 items
- arXiv q-bio: 23 items


## Eli Lilly Press Releases

- **[Lilly's Taltz (ixekizumab) and Zepbound (tirzepatide) used together delivered superior efficacy in first-of-its-kind Phase 3b trial for adults with active psoriatic arthritis and obesity or overweight](https://investor.lilly.com/news-releases/news-release-details/lillys-taltz-ixekizumab-and-zepbound-tirzepatide-used-together)**  
  _Thu, 08 Jan 2026 14:00:00 -0500_  
  At 36 weeks, the TOGETHER-PsA study met its primary endpoint of 50% improvement in psoriatic arthritis (PsA) activity based on ACR50 in addition to ‚â•10% weight reduction with concomitant Taltz and Zepbound compared to Taltz monotherapy¬†¬† In a key secondary endpoint, use of Taltz and Zepbound


## Endpoints News

- **[Roche returns to Chinese biotech MediLink for another ADC pact](https://endpoints.news/roche-returns-to-chinese-biotech-medilink-for-another-adc-pact/)**  
  _Fri, 09 Jan 2026 13:15:44 +0000_  
  Roche has signed another licensing deal with its China-based partner MediLink, this time focused on an antibody-drug conjugate for solid tumors that targets B7-H3.

 The Swiss drugmaker will obtain exclusive rights to MediLink‚Äôs drug, called ...

- **[AirNexis gets $200M to test China-derived COPD drug](https://endpoints.news/airnexis-lands-200m-to-test-china-derived-copd-drug/)**  
  _Fri, 09 Jan 2026 13:00:40 +0000_  
  Another biotech has latched onto the China-to-US model, putting money behind a China asset that will be advanced by an American startup.

 Palo Alto-based AirNexis Therapeutics will get $200 million from investors to advance a ...

- **[Enliven‚Äôs Phase 1 leukemia pill data look competitive with Novartis and Terns](https://endpoints.news/enlivens-phase-1-leukemia-pill-data-look-competitive-with-novartis-and-terns/)**  
  _Fri, 09 Jan 2026 12:07:40 +0000_  
  It appears that Enliven Therapeutics‚Äô decision to pivot away from a solid tumor drug now seems like a wise one.

 Enliven said on Thursday that its tyrosine kinase ...

- **[Eli Lilly, Chai Discovery sign AI software deal](https://endpoints.news/eli-lilly-chai-discovery-sign-ai-software-deal/)**  
  _Fri, 09 Jan 2026 12:00:23 +0000_  
  Eli Lilly has signed one of the pharma industry's largest AI software deals with Chai Discovery, a hard-charging startup that makes drug-designing AI models.

 While the companies aren't publicly disclosing financial details, Lilly will pay ...

- **[Medipost gets $140M to take Korean stem cell therapy into US](https://endpoints.news/medipost-gets-140m-to-take-korean-stem-cell-therapy-into-us/)**  
  _Fri, 09 Jan 2026 11:30:58 +0000_  
  A Seoul-area biotech has raised $140 million to bring its allogeneic cell therapy, approved in South Korea since 2012, into the US and Japan.

 Medipost Co. raised the funding for its Cambridge, MA subsidiary Medipost ...

- **[Gene editing pioneers launch first startup focused on custom CRISPR therapies](https://endpoints.news/gene-editing-pioneers-launch-first-startup-focused-on-custom-crispr-therapies/)**  
  _Fri, 09 Jan 2026 11:00:27 +0000_  
  Last spring, gene editing scientists stunned the world when they created a bespoke CRISPR therapy to fix a unique genetic mutation that left a boy, known as Baby KJ, hospitalized since birth. The treatment stabilized ...

- **[Aktis lands biotech's first IPO of 2026, raising $318M for radiopharmaceuticals](https://endpoints.news/aktis-lands-biotechs-first-ipo-of-2026-raising-318m-for-radiopharmaceuticals/)**  
  _Fri, 09 Jan 2026 02:42:48 +0000_  
  An Eli Lilly-partnered radiopharmaceutical startup will kick open the doors for biotech's 2026 IPO class.

 On Friday, Aktis Oncology will start trading on the Nasdaq. The initial public offering raised $318 million in gross proceeds ...

- **[Illumina hires Eric Green as chief medical officer](https://endpoints.news/former-nih-director-eric-green-to-join-illumina-as-chief-medical-officer/)**  
  _Thu, 08 Jan 2026 20:30:33 +0000_  
  Eric Green, a pioneering geneticist and former director of the National Human Genome Research Institute, is slated to become the chief medical officer of the genomics giant Illumina, Endpoints News learned exclusively.

 Green said the ...

- **[FDA staff cuts mostly didn't impact new drug review timelines, analysis finds](https://endpoints.news/fda-staff-cuts-mostly-didnt-impact-new-drug-review-timelines-analysis-finds/)**  
  _Thu, 08 Jan 2026 19:20:55 +0000_  
  Despite thousands of FDA staff cuts, retirements and leadership departures in 2025, the agency‚Äôs drug reviewers managed to hold the line and meet just about all of its user-fee commitments for new drug reviews.  ...

- **[New Lilly data suggest Zepbound boosted effect of autoimmune drug](https://endpoints.news/new-lilly-data-suggest-zepbound-boosted-effect-of-autoimmune-drug/)**  
  _Thu, 08 Jan 2026 19:00:03 +0000_  
  New Phase 3b data from Eli Lilly suggest that its blockbuster weight loss drug helped boost the efficacy of an autoimmune treatment in select patients with active psoriatic arthritis who were overweight or obese.  ...

- **[FDA rejects Vanda‚Äôs jet lag drug following yearslong dispute](https://endpoints.news/fda-rejects-vandas-jet-lag-drug-following-yearslong-dispute/)**  
  _Thu, 08 Jan 2026 16:19:50 +0000_  
  The FDA‚Äôs re-review of Vanda Pharmaceuticals‚Äô jet lag treatment Hetlioz has resulted in a rejection, the latest twist in a yearslong dispute.

 Vanda said Thursday that the agency determined its clinical ...

- **[MoonLake revives FDA push; Biotech trio to debut in Hong Kong](https://endpoints.news/moonlake-revives-fda-push-biotech-trio-to-debut-in-hong-kong/)**  
  _Thu, 08 Jan 2026 16:15:06 +0000_  
  Plus, news about Catalio Capital, Rapport, Servier and Iktos, as well as Century, among others

 üìà MoonLake Immunotherapeutics seeks approval in rare skin disease despite Phase 3 miss: The biotech‚Äôs stock jumped by about 30 ...

- **[Deregulating the rapidly evolving digital health industry](https://endpoints.news/deregulating-the-rapidly-evolving-digital-health-industry/)**  
  _Thu, 08 Jan 2026 15:34:52 +0000_  
  If today‚Äôs newsletter is any indication, AI in healthcare is going to be unavoidable this year. In the last few days:
 
 OpenAI announced ChatGPT Health, a new product ...


## Fierce Biotech

- **[<a href="https://www.fiercebiotech.com/biotech/baby-kj-scientist-launches-personalized-crispr-therapy-startup" hreflang="en">Baby KJ scientist launches personalized CRISPR therapy startup</a>](https://www.fiercebiotech.com/biotech/baby-kj-scientist-launches-personalized-crispr-therapy-startup)**  
  _Jan 9, 2026 8:43am_  
  Menlo Ventures has made a $16 million bet that the ‚Äúbaby KJ‚Äù custom CRISPR therapy success story is repeatable.

- **[<a href="https://www.fiercebiotech.com/biotech/fierce-biotech-layoff-tracker-2026" hreflang="en">Fierce Biotech Layoff Tracker 2026: InflaRx reduces headcount; Tessera trims workforce</a>](https://www.fiercebiotech.com/biotech/fierce-biotech-layoff-tracker-2026)**  
  _Dec 23, 2025 10:11am_  
  As always, if you know of layoffs occurring at a biotech, please reach out to the Fierce Biotech editorial team.

- **[<a href="https://www.fiercebiotech.com/biotech/chutes-ladders-former-roche-oncology-head-turns-tubulis" hreflang="en">Chutes &amp; Ladders‚ÄîFormer Roche oncology head turns to Tubulis </a>](https://www.fiercebiotech.com/biotech/chutes-ladders-former-roche-oncology-head-turns-tubulis)**  
  _Jan 8, 2026 5:32pm_  
  After netting a $361 million series C funding round in October, 2024 Fierce 15 winner Tubulis has reeled in a big name for its chief medical officer spot in Charles Fuchs, M.D. Fuchs is a world-renowned oncology expert who split from Roche last month after five years of service as the company‚Äôs SVP and global head of‚Ä¶

- **[<a href="https://www.fiercebiotech.com/biotech/roche-returns-medilink-promise-570m-near-term-payments-another-adc" hreflang="en">Roche returns to MediLink with promise of $570M near-term payments for another ADC</a>](https://www.fiercebiotech.com/biotech/roche-returns-medilink-promise-570m-near-term-payments-another-adc)**  
  _Jan 9, 2026 5:41am_  
  Roche has got in on the B7-H3 action, agreeing to $570 million in near-term payments to existing partner MediLink Therapeutics for an ADC targeting the immune checkpoint protein.

- **[<a href="https://www.fiercebiotech.com/biotech/1st-biotech-ipo-2026-sees-aktis-bring-318m-upsized-offering" hreflang="en">1st biotech IPO of 2026 sees Aktis bring in $318M via upsized offering</a>](https://www.fiercebiotech.com/biotech/1st-biotech-ipo-2026-sees-aktis-bring-318m-upsized-offering)**  
  _Jan 9, 2026 4:54am_  
  Aktis Oncology exceeded its own expectations for its IPO in a good omen for those hoping for a more inviting public market this year.

- **[<a href="https://www.fiercebiotech.com/medtech/illumina-hires-former-nhgri-director-eric-green-new-chief-medical-officer" hreflang="en">Illumina hires former NHGRI Director Eric Green as new chief medical officer </a>](https://www.fiercebiotech.com/medtech/illumina-hires-former-nhgri-director-eric-green-new-chief-medical-officer)**  
  _Jan 9, 2026 3:16am_  
  Nearly a year after leaving his position as longtime director of the National Human Genome Research Institute, Eric Green, M.D., Ph.D., will now step into the commercial life sciences world as the new chief medical officer of Illumina.

- **[<a href="https://www.fiercebiotech.com/biotech/ollin-eyes-phase-3-after-topping-vabysmo-head-head-trial-ollins-bispecific-antibody-tops" hreflang="en">Ollin eyes phase 3 after bispecific tops Vabysmo in early-stage trial, clearing more retinal disease faster</a>](https://www.fiercebiotech.com/biotech/ollin-eyes-phase-3-after-topping-vabysmo-head-head-trial-ollins-bispecific-antibody-tops)**  
  _Jan 8, 2026 2:52pm_  
  After unsheathing just a few months ago, Ollin Biosciences‚Äô next-gen bispecific antibody cleared more disease faster than Genentech‚Äôs Vabysmo for patients with diabetic macular edema (DME) in an early-stage study.

- **[<a href="https://www.fiercebiotech.com/cro/longtime-charles-river-leader-jim-foster-retire-chief-operating-officer-will-take-helm" hreflang="en">Longtime Charles River leader Jim Foster to retire, with COO set to take the helm</a>](https://www.fiercebiotech.com/cro/longtime-charles-river-leader-jim-foster-retire-chief-operating-officer-will-take-helm)**  
  _Jan 8, 2026 12:22pm_  
  James Foster‚Äôs legendary half-century run at Charles River Laboratories is coming to an end. After more than 30 years as president and CEO, Foster plans to retire from the CRO giant on May 5, right after the company‚Äôs annual shareholder meeting.

- **[<a href="https://www.fiercebiotech.com/biotech/gsk-inks-model-deal-50m-bet-noetiks-cancer-ai-platform" hreflang="en">GSK inks a model deal in $50M bet on Noetik's cancer AI platform</a>](https://www.fiercebiotech.com/biotech/gsk-inks-model-deal-50m-bet-noetiks-cancer-ai-platform)**  
  _Jan 8, 2026 9:56am_  
  GSK has committed $50 million in upfront capital and near-term milestones to secure a license to two cancer research foundation models from Noetik.

- **[<a href="https://www.fiercebiotech.com/biotech/lilly-buys-inflammation-biotech-venytx-12b-wake-parkinsons-cardiovascular-readouts" hreflang="en">Lilly buys inflammation biotech Ventyx for $1.2B in wake of Parkinson's, CV readouts</a>](https://www.fiercebiotech.com/biotech/lilly-buys-inflammation-biotech-venytx-12b-wake-parkinsons-cardiovascular-readouts)**  
  _Jan 8, 2026 5:04am_  
  Ventyx has achieved its goal of securing Big Pharma commitment to its pipeline, with Eli Lilly swooping in to buy the inflammation biotech outright for $1.2 billion.


## arXiv q-bio

- **[When evolution realizes large deviations of fitness: from speciation to dynamical phase transitions](https://arxiv.org/abs/2601.04325)**  
  _Fri, 09 Jan 2026 00:00:00 -0500_  
  arXiv:2601.04325v1 Announce Type: new 
Abstract: We explore the connection between evolution and large-deviation theory. To do so, we study evolutionary dynamics in which individuals experience mutations, reproduction, and selection using variants of the Moran model. We show that, in the large population size limit, t‚Ä¶

- **[Thermodynamic Constraints Drive Hierarchical Preemption in Cellular Decision-Making: A Hybrid Petri Net Framework with Application to Bacillus subtilis Sporulation](https://arxiv.org/abs/2601.04335)**  
  _Fri, 09 Jan 2026 00:00:00 -0500_  
  arXiv:2601.04335v1 Announce Type: new 
Abstract: Cellular decision-making under stress involves rapid pathway selection despite energy scarcity. Here we demonstrate that thermodynamic constraints actively drive energy-efficient sporulation, where continuous metabolic sources enable system robustness through dynamic en‚Ä¶

- **[Biomechanically Informed Image Registration for Patient-Specific Aortic Valve Strain Analysis](https://arxiv.org/abs/2601.04375)**  
  _Fri, 09 Jan 2026 00:00:00 -0500_  
  arXiv:2601.04375v1 Announce Type: new 
Abstract: Aortic valve (AV) biomechanics play a critical role in maintaining normal cardiac function. Pathological variations, particularly in bicuspid aortic valves (BAVs), alter leaflet loading, increase strain, and accelerate disease progression. Accurate, patient-specific cha‚Ä¶

- **[Past Psychedelic Use Predicts Divergent Thinking](https://arxiv.org/abs/2601.04380)**  
  _Fri, 09 Jan 2026 00:00:00 -0500_  
  arXiv:2601.04380v1 Announce Type: new 
Abstract: Psychedelics have shown potential in treating a range of mental health conditions, yet far less is known about their impact on creativity. This study examined three components of creativity-divergent thinking, cognitive reflection, and insight in a large sample (N = 5,9‚Ä¶

- **[Identifying expanding TCR clonotypes with a longitudinal Bayesian mixture model and their associations with cancer patient prognosis, metastasis-directed therapy, and VJ gene enrichment](https://arxiv.org/abs/2601.04536)**  
  _Fri, 09 Jan 2026 00:00:00 -0500_  
  arXiv:2601.04536v1 Announce Type: new 
Abstract: Examination of T-cell receptor (TCR) clonality has become a way of understanding immunologic response to cancer and its interventions in recent years. An aspect of these analyses is determining which receptors expand or contract statistically significantly as a function‚Ä¶

- **[Structural-dynamic behavior of histamine in solution: the role of water models](https://arxiv.org/abs/2601.04874)**  
  _Fri, 09 Jan 2026 00:00:00 -0500_  
  arXiv:2601.04874v1 Announce Type: new 
Abstract: A highly diluted aqueous solution of histamine was studied by molecular dynamics using the TIP3P and SPC/E water models. It was shown that the local structure of the solution around histamine is determined by local Coulomb interactions and hydrogen bonds and is practica‚Ä¶

- **[Effects of T-type and L-type calcium currents on synchronized activity patterns in a model subthalamo-pallidal network](https://arxiv.org/abs/2601.04909)**  
  _Fri, 09 Jan 2026 00:00:00 -0500_  
  arXiv:2601.04909v1 Announce Type: new 
Abstract: Synchronized rhythmic oscillatory activity in the beta frequency band in the basal ganglia (BG) is a hallmark of Parkinson's disease (PD). Recent experiments and theoretical studies have demonstrated the crucial roles of T-type and L-type calcium currents in shaping the‚Ä¶

- **[Cell size control in bacteria is modulated through extrinsic noise, single-cell- and population-growth](https://arxiv.org/abs/2601.05193)**  
  _Fri, 09 Jan 2026 00:00:00 -0500_  
  arXiv:2601.05193v1 Announce Type: new 
Abstract: Living cells maintain size homeostasis by actively compensating for size fluctuations. Here, we present two stochastic maps that unify phenomenological models by integrating fluctuating single-cell growth rates and size-dependent noise mechanisms with cell size control.‚Ä¶

- **[Active Sensing Shapes Real-World Decision-Making through Dynamic Evidence Accumulation](https://arxiv.org/abs/2601.04214)**  
  _Fri, 09 Jan 2026 00:00:00 -0500_  
  arXiv:2601.04214v1 Announce Type: cross 
Abstract: Human decision-making heavily relies on active sensing, a well-documented cognitive behaviour for evidence gathering to accommodate ever-changing environments. However, its operational mechanism in the real world remains non-trivial. Currently, an in-laboratory paradi‚Ä¶

- **[Where do We Poop? City-Wide Simulation of Defecation Behavior for Wastewater-Based Epidemiology](https://arxiv.org/abs/2601.04231)**  
  _Fri, 09 Jan 2026 00:00:00 -0500_  
  arXiv:2601.04231v1 Announce Type: cross 
Abstract: Wastewater surveillance, which regularly examines the pathogen biomarkers in wastewater samples, is a valuable tool for monitoring infectious diseases circulating in communities. Yet, most wastewater-based epidemiology methods, which use wastewater surveillance result‚Ä¶

- **[Systems Explaining Systems: A Framework for Intelligence and Consciousness](https://arxiv.org/abs/2601.04269)**  
  _Fri, 09 Jan 2026 00:00:00 -0500_  
  arXiv:2601.04269v1 Announce Type: cross 
Abstract: This paper proposes a conceptual framework in which intelligence and consciousness emerge from relational structure rather than from prediction or domain-specific mechanisms. Intelligence is defined as the capacity to form and integrate causal connections between sign‚Ä¶

- **[Transformer-Based Multi-Modal Temporal Embeddings for Explainable Metabolic Phenotyping in Type 1 Diabetes](https://arxiv.org/abs/2601.04299)**  
  _Fri, 09 Jan 2026 00:00:00 -0500_  
  arXiv:2601.04299v1 Announce Type: cross 
Abstract: Type 1 diabetes (T1D) is a highly metabolically heterogeneous disease that cannot be adequately characterized by conventional biomarkers such as glycated hemoglobin (HbA1c). This study proposes an explainable deep learning framework that integrates continuous glucose‚Ä¶

- **[Phasor Agents: Oscillatory Graphs with Three-Factor Plasticity and Sleep-Staged Learning](https://arxiv.org/abs/2601.04362)**  
  _Fri, 09 Jan 2026 00:00:00 -0500_  
  arXiv:2601.04362v1 Announce Type: cross 
Abstract: Phasor Agents are dynamical systems whose internal state is a Phasor Graph: a weighted graph of coupled Stuart-Landau oscillators. A Stuart-Landau oscillator is a minimal stable "rhythm generator" (the normal form near a Hopf bifurcation); each oscillator is treated a‚Ä¶

- **[Reconstructing MSM Sexual Networks to Guide PrEP Distribution Strategies for HIV Prevention](https://arxiv.org/abs/2601.04434)**  
  _Fri, 09 Jan 2026 00:00:00 -0500_  
  arXiv:2601.04434v1 Announce Type: cross 
Abstract: Men who have sex with men (MSM) remain disproportionately affected by HIV, yet optimizing the distribution of pre-exposure prophylaxis (PrEP) in this population remains a major public health challenge. Current PrEP eligibility guidelines and most modelling studies do‚Ä¶

- **[Entrainment of the suprachiasmatic nucleus network by a light-dark cycle](https://arxiv.org/abs/2601.04926)**  
  _Fri, 09 Jan 2026 00:00:00 -0500_  
  arXiv:2601.04926v1 Announce Type: cross 
Abstract: The synchronization of biological activity with the alternation of day and night (circadian rhythm) is performed in the brain by a group of neurons, constituting the suprachiasmatic nucleus (SCN). The SCN is divided into two subgroups of oscillating cells: the ventro-‚Ä¶

- **[H\'an D\=an Xu\'e B\`u (Mimicry) or Q\=ing Ch\=u Y\'u L\'an (Mastery)? A Cognitive Perspective on Reasoning Distillation in Large Language Models](https://arxiv.org/abs/2601.05019)**  
  _Fri, 09 Jan 2026 00:00:00 -0500_  
  arXiv:2601.05019v1 Announce Type: cross 
Abstract: Recent Large Reasoning Models trained via reinforcement learning exhibit a "natural" alignment with human cognitive costs. However, we show that the prevailing paradigm of reasoning distillation -- training student models to mimic these traces via Supervised Fine-Tuni‚Ä¶

- **[Geometric developmental principles for the emergence of brain-like weighted and directed neuronal networks](https://arxiv.org/abs/2601.05021)**  
  _Fri, 09 Jan 2026 00:00:00 -0500_  
  arXiv:2601.05021v1 Announce Type: cross 
Abstract: Brain networks exhibit remarkable structural properties, including high local clustering, short path lengths, and heavy-tailed weight and degree distributions. While these features are thought to enable efficient information processing with minimal wiring costs, the f‚Ä¶

- **[Mechanics of axis formation in $\textit{Hydra}$](https://arxiv.org/abs/2601.05220)**  
  _Fri, 09 Jan 2026 00:00:00 -0500_  
  arXiv:2601.05220v1 Announce Type: cross 
Abstract: The emergence of a body axis is a fundamental step in the development of multicellular organisms. In simple systems such as $\textit{Hydra}$, growing evidence suggests that mechanical forces generated by collective cellular activity play a central role in this process‚Ä¶

- **[Oscillatory Regimes in a Game-Theoretic Model for Mosquito Population Dynamics under Breeding Site Control](https://arxiv.org/abs/2601.05222)**  
  _Fri, 09 Jan 2026 00:00:00 -0500_  
  arXiv:2601.05222v1 Announce Type: cross 
Abstract: Mosquito-borne diseases remain a major public-health threat, and the effective control of mosquito populations requires sustained household participation in removing breeding sites. While environmental drivers of mosquito oscillations have been extensively studied, th‚Ä¶

- **[Modeling flexible behavior with remapping-based hippocampal sequence learning](https://arxiv.org/abs/2407.14708)**  
  _Fri, 09 Jan 2026 00:00:00 -0500_  
  arXiv:2407.14708v3 Announce Type: replace 
Abstract: Animals flexibly change their behavior depending on context. It is reported that the hippocampus is one of the most prominent regions for contextual behaviors, and its sequential activity shows context dependency. However, how such context-dependent sequential activ‚Ä¶

- **[Bayesian Re-Analysis of the Phylogenetic Topology of Early SARS-CoV-2 Case Sequences](https://arxiv.org/abs/2510.01484)**  
  _Fri, 09 Jan 2026 00:00:00 -0500_  
  arXiv:2510.01484v4 Announce Type: replace 
Abstract: A much-cited 2022 paper by Pekar et al. claimed that Bayesian analysis of the molecular phylogeny of early SARS-CoV-2 cases indicated that it was more likely that two successful introductions to humans had occurred than that just one had. Here I show that after corr‚Ä¶

- **[Vertical Ground Reaction Forces Waveform Flattening during Gait in Women with Knee Osteoarthritis](https://arxiv.org/abs/2510.16942)**  
  _Fri, 09 Jan 2026 00:00:00 -0500_  
  arXiv:2510.16942v2 Announce Type: replace 
Abstract: Background. Knee Osteoarthritis (OA) is a common chronic joint condition, and its prevalence increases with age. This study aims to examine whether flattened vertical ground reaction force (vGRF) waveforms and reduced knee range of motion (RoM) occur together during‚Ä¶

- **[A new stochastic SIS-type modelling framework for analysing epidemic dynamics in continuous space](https://arxiv.org/abs/2502.02106)**  
  _Fri, 09 Jan 2026 00:00:00 -0500_  
  arXiv:2502.02106v2 Announce Type: replace-cross 
Abstract: We propose a new stochastic epidemiological model defined in a continuous space of arbitrary dimension, based on SIS dynamics implemented in a spatial $\Lambda$-Fleming-Viot (SLFV) process. The model can be described by as little as three parameters, and is du‚Ä¶
